Loading…
Dividends declared (per SOCE filings): FY2022 0 · FY2023 422 — 2-yr total 422
Operates in Pharma — Retail - Pharmacy. Per the activity note to the FY2023 annual report, the company retails and wholesales pharmaceutical, medical and orthopedic products in specialized pharmacies.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|
| Total Revenue | 3,168 | 4,344 | 5,807 | 7,150 | 8,724 | 10,932 | +28.1% |
| Total COGS | 1,205 | 1,511 | 2,352 | 2,566 | 2,967 | 3,486 | +23.7% |
| Gross Profit | 1,963 | 2,832 | 3,455 | 4,585 | 5,757 | 7,446 | +30.6% |
| Gross Margin | 62.0% | 65.2% | 59.5% | 64.1% | 66.0% | 68.1% | |
| 1,180 | 1,374 | 1,476 | 2,017 | 2,440 | 5,188 | +34.5% | |
| EBITDA | 784 | 1,459 | 1,979 | 2,567 | 3,318 | 2,258 | +23.6% |
| EBITDA Margin | 24.7% | 33.6% | 34.1% | 35.9% | 38.0% | 20.7% | |
| Total D&A | 49 | 50 | 96 | 227 | 108 | 182 | +30.0% |
| EBIT / Operating Income | 734 | 1,408 | 1,883 | 2,340 | 3,210 | 2,075 | +23.1% |
| Total Interest Income | 0 | 0 | 0 | 0 | 0 | 2 | |
| Total Interest Expense | 108 | 93 | 136 | 164 | 95 | 207 | +13.8% |
| 26 | 58 | 645 | 674 | 206 | 79 | +25.0% | |
| Profit Before Tax | 600 | 1,257 | 1,102 | 2,850 | 3,321 | 1,792 | +24.4% |
| Total Income Tax | 17 | 7 | 20 | 102 | 80 | 84 | +36.8% |
| Net Profit / (Loss) | 583 | 1,249 | 1,149 | 2,345 | 2,662 | 1,632 | +22.9% |
| Net Margin | 18.4% | 28.8% | 19.8% | 32.8% | 30.5% | 14.9% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →